Meeting Overview - The fifth meeting of the board of directors was held on August 12, 2025, with all seven directors present, meeting the legal quorum requirements [1] - The meeting was chaired by Chairman Sun Zhen, and the procedures complied with the Company Law and the company's articles of association [1] Resolutions Passed - A resolution was passed regarding a sales employee suspected of embezzlement through forgery of company documents, leading to a report to the Beijing Public Security Bureau [1] - The company will correct accounting errors from Q4 2023 to Q1 2025 using retrospective restatement, affecting multiple financial reports including the 2023 annual report and 2024 quarterly reports [1] Employee Stock Ownership Plan - The board decided to revoke the shares and benefits of an employee in the stock ownership plan due to legal violations, impacting the performance assessment of their department [2] - The resolution regarding the 2025 semi-annual report was approved, confirming that it accurately reflects the company's operational status without any misleading statements [2] Fund Management - The board reviewed the management of raised funds for the first half of 2025, ensuring compliance with relevant regulations and preparing a special report on fund usage [3] - A resolution was passed to establish a dedicated fund account for a subsidiary, aimed at improving fund utilization efficiency and aligning with the company's long-term development needs [3]

Core Viewpoint - Shenzhen BGI Intelligent Manufacturing Technology Co., Ltd. has proposed a 2024 employee stock ownership plan aimed at aligning the interests of employees and shareholders, enhancing corporate governance, and promoting long-term sustainable development [3][10][21]. Summary by Sections 1. Purpose and Principles of the Plan - The employee stock ownership plan is designed to establish a profit-sharing mechanism between employees and shareholders, improve corporate governance, and enhance employee motivation and creativity [10][11]. - Participation in the plan is voluntary, and the company will not impose mandatory participation on employees [11][12]. 2. Participants and Eligibility - The plan will include a maximum of 35 employees, consisting of directors (excluding independent directors), supervisors, senior management, and core business personnel [4][12]. - The selection of participants will be based on their contributions to the company's core business and strategic direction [15]. 3. Funding and Stock Source - The total funding for the plan will not exceed RMB 37.7868 million, with each unit priced at RMB 1.00 [4][13]. - The shares will be sourced from the company's repurchased A-shares, with a maximum holding of 1.445 million shares, accounting for 0.35% of the total share capital [5][18]. 4. Pricing and Valuation - The share purchase price is set at RMB 26.15 per share, which is based on the average trading price prior to the announcement of the plan [15][16]. - The pricing strategy aims to ensure fairness and reasonableness, reflecting the company's operational status and industry conditions [16]. 5. Lock-up and Vesting Period - The plan has a duration of 48 months, with shares vesting in two phases: 50% after 12 months and the remaining 50% after 24 months [6][20]. - The vesting of shares is contingent upon the company's performance and individual assessments of the participants [20][21]. 6. Management and Governance - The plan will be managed by a dedicated management committee, which will oversee daily operations and represent the interests of the participants [24][25]. - The management committee is responsible for ensuring compliance with legal and regulatory requirements and safeguarding the rights of the participants [25][29]. 7. Performance Assessment - The performance assessment will be based on company-wide revenue growth and individual performance metrics, with specific targets set for the years 2024 and 2025 [21][22]. - The assessment results will determine the unlock ratios for the shares, aligning employee incentives with company performance [22][23].

Core Viewpoint - Shenzhen BGI Genomics Co., Ltd. has proposed a 2024 Employee Stock Ownership Plan (ESOP) aimed at aligning the interests of employees and shareholders, enhancing corporate governance, and promoting long-term sustainable development [3][12][16]. Group 1: Plan Overview - The ESOP is designed to comply with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [3][12]. - The plan will be managed by a dedicated committee, which will represent the interests of the participants and ensure compliance with legal requirements [9][25]. - The total amount to be raised through the plan is capped at RMB 37.7868 million, with each unit priced at RMB 1.00 [4][14]. Group 2: Participants and Structure - The plan will involve a maximum of 35 employees, including directors (excluding independent directors), supervisors, senior management, and core business personnel [4][13]. - The stock purchase price is set at RMB 26.15 per share, which is based on a fair valuation considering the company's performance and market conditions [15][16]. - The total shares allocated under the plan will not exceed 1.445 million shares, representing approximately 0.35% of the company's total share capital [5][18]. Group 3: Lock-up and Vesting - The plan has a duration of 48 months, with shares unlocking in two phases: 50% after 12 months and the remaining 50% after 24 months [6][21]. - The unlocking of shares is contingent upon the company's performance meeting specific revenue growth targets, which are set against the 2023 revenue of RMB 2.709 billion [22][23]. Group 4: Financial Management and Compliance - The company will not provide any financial assistance to participants, ensuring that all funding comes from employees' legal salaries and self-raised funds [4][14]. - The management committee will oversee the daily operations of the ESOP, ensuring that all actions comply with the established guidelines and protect the rights of the participants [25][30]. - The plan includes provisions for adjusting the stock purchase price in the event of corporate actions such as stock splits or dividends [16][17].

Core Points - Shenzhen BGI Tech Co., Ltd. held the first meeting of the 2024 Employee Stock Ownership Plan on August 21, 2025, with 25 attendees representing 34,797,962 shares, accounting for 94.40% of the total shares in the plan [1][2] - The meeting approved the revised draft of the 2024 Employee Stock Ownership Plan and its summary to ensure the smooth implementation of the plan and protect the rights of shareholders [1] - The meeting also approved the revised management measures for the 2024 Employee Stock Ownership Plan, aligning with relevant regulations and actual circumstances [2] Summary by Sections Employee Stock Ownership Plan - The 2024 Employee Stock Ownership Plan was discussed and approved, with a focus on performance assessment indicators at the company level to ensure its effectiveness [1] - The plan's total shares represented by attendees was 34,797,962, with unanimous approval (100%) from those present [2] Management Measures - The management measures for the 2024 Employee Stock Ownership Plan were revised to align with the updated draft and ensure smooth implementation [2] - The voting results showed full support with no opposition or abstentions [2]

Core Viewpoint - Shenzhen BGI Genomics Co., Ltd. plans to revise its 2024 restricted stock incentive plan and employee stock ownership plan to enhance employee motivation and align with the company's strategic goals in the context of the evolving market environment [10][11]. Summary by Sections Incentive Plan Overview - The incentive plan involves granting restricted stocks to key personnel, including directors, senior management, and core technical staff, to align their interests with the company's long-term performance [1][4]. Necessary Procedures - The company has followed necessary procedures, including board meetings and shareholder approvals, to implement the incentive plan and employee stock ownership plan [5][6][7]. Revision Reasons - The revision is driven by the need to adapt to changes in the external environment and to focus on increasing market share in the gene sequencing equipment sector, which is critical for long-term revenue growth [10][11]. Revised Performance Metrics - The revised performance metrics will include non-related party gene sequencing instrument sales as a key performance indicator, aiming to enhance the company's competitive position and employee engagement [11][12]. Conclusion - The independent financial advisor confirms that the revisions to the incentive plan and employee stock ownership plan have met the necessary review and disclosure obligations and are pending shareholder approval for implementation [14][15].

证券代码：688114 证券简称：华大智造 公告编号：2025-051 深圳华大智造科技股份有限公司 关于修订 2024 年限制性股票激励计划及 2024 年员工持股计划 相关文件的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 深圳华大智造科技股份有限公司（以下简称"公司"或"华大智造"）于 议，审议通过《关于公司〈2024年限制性股票激励计划（草案修订稿）〉及摘要 的议案》《关于公司〈2024年限制性股票激励计划实施考核管理办法（修订稿）〉 的议案》《关于公司〈2024年员工持股计划（草案修订稿）〉及摘要的议案》《关 于公司〈2024年员工持股计划管理办法（修订稿）〉的议案》。为发挥激励作用， 达到激励目的，公司董事会认为应当新增2024年限制性股票激励计划（以下简称 "本激励计划"）、2024年员工持股计划所涉公司层面业绩考核指标，同意对《2024 年限制性股票激励计划（草案）》《2024年限制性股票激励计划（草案）摘要公 告》 《2024年限制性股票激励计划实施考核管理办法》 《2024年员工持股计划（草 司2024年限制性股票激励计划（草案）〉 ...

深圳华大智造科技股份有限公司 第一章 总则 第二条 持股计划的基本原则 第一条 为规范深圳华大智造科技股份有限公司（以下简称"华大智造"或"公司"） 施，根据《中华人民共和国公司法》（以下简称"《公司法》"）《中华人民共和国 证券法》以下简称"《证券法》"、中国证监会《关于上市公司实施员工持股计划试 点的指导意见》（以下简称"《指导意见》"）、《上海证券交易所科创板上市公司 自律监管指引第 1 号——规范运作》（以下简称"《自律监管指引第 1 号》"）等 相关法律、行政法规、规章、规范性文件和《公司章程》《深圳华大智造科技股份 有限公司 2024 年员工持股计划（草案修订稿）》之规定，特制定《深圳华大智造 科技股份有限公司 2024 年员工持股计划管理办法（修订稿）》（以下简称"本办法" 或"《持股计划管理办法》"）。 第二章 持股计划的制定 （一）依法合规原则 公司实施持股计划，严格按照法律、行政法规的规定履行程序，真实、准确、 完整、及时地实施信息披露。任何人不得利用持股计划进行内幕交易、操纵证券市 场等证券欺诈行为。 （二）自愿参与原则 公司实施持股计划遵循公司自主决定，员工自愿参加，公司不以摊派、强行 ...

证券代码：002714 证券简称：牧原股份 公告编号：2025-082 债券代码：127045 债券简称：牧原转债 牧原食品股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 牧原食品股份有限公司（以下简称"公司"）第五届董事会第八次会议于 2025 年 8 月 22 日以通讯的方式召开。召开本次会议的通知及相关会议资料已于 2025 年 8 月 21 日通过书面、电子邮件等方式送达各位董事、监事和高级管理人员（召 集人已在会议上就通知时限作出说明）。本次会议应出席董事 7 人，实际出席董 事 7 人。公司监事会成员和高级管理人员列席了本次会议，会议的召开符合《中 华人民共和国公司法》等法律、法规及《公司章程》的规定，会议合法有效。 一、会议以 5 票同意，0 票反对，0 票弃权的表决结果审议通过了《关于牧 原食品股份有限公司 2025 年经营者持股计划（草案）及其摘要的议案》，并同 意将该议案提交股东大会审议。关联董事曹治年先生、杨瑞华女士回避表决。 《牧原食品股份有限公司 2025 年经营者持股计划（草案）》详见巨潮资讯网 《牧原食品股份有限公司 ...

Core Viewpoint - The company is set to implement a 2025 employee stock ownership plan, which has been reviewed and deemed compliant with relevant laws and regulations, ensuring it does not harm the interests of the company or its shareholders, particularly minority shareholders [1][2]. Group 1 - The company has the qualifications to implement the 2025 stock ownership plan as per the prohibitions outlined in relevant laws and regulations [1]. - The decision-making process for the stock ownership plan is legal and effective, with no harm to the interests of the company or all shareholders, and no forced participation or financial assistance provided to participants [1][2]. - The plan aligns with the company's long-term development needs and is expected to enhance management efficiency and employee motivation, contributing to strategic goals and sustainable development [2].

北京市朝阳区建外大街丁 12 号英皇集团中心 8、9、11 层 电话/Tel.:010-50867666 传真/Fax:010-56916450 网址/Website:www.kangdalawyers.com 北京 西安 深圳 海口 上海 广州 杭州 沈阳 南京 天津 菏泽 成都 苏州 呼和浩特 香港 武汉 郑州 长沙 厦门 重庆 合肥 宁波 济南 昆明 南昌 北京市康达律师事务所 康达法意字【2025】第 0426 号 二〇二五年八月 法律意见书 关于 牧原食品股份有限公司 之 法律意见书 北京市康达律师事务所 关于 牧原食品股份有限公司 之 法律意见书 康达法意字【2025】第 0426 号 致：牧原食品股份有限公司 北京市康达律师事务所（以下简称为"本所"）接受牧原食品股份有限公司（以 下简称"公司"或"牧原股份"）的委托，担任牧原股份 2025 年骨干员工持股计划 （以下简称"员工持股计划"或"本次骨干员工持股计划"）的法律顾问，根据《中 华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）、中国证券监督管理委员会《关于上市公司实施员工 持股计划试点的 ...